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Middle T (mn, the oncogene of murine polyomavirus, causes transformation of rat fibroblasts by activating a number of 
signal transducing pathways usually used by polypeptide growth factors and their receptors. Here, we report data regarding 
the activation of signal transducing pathways involving phospholipase 0 {PL-0). The hydrolysis of phospholipids by PL-0 
produces phosphatidic acid {PA), a compound with multiple biological effects. The PA content of cells expressing wild-type 
mT, introduced via a number of different methods, is approximately 50% higher than their untransformed counterparts. This 
increase in cellular PA content is associated with an approximately 65% increase in PL-0 activity in cells expressing wild-
type mT. We have also examined the effects of a number of site-directed mutants of mT, on both cellular PA levels and on 
PL-0 activity. Mutants that do not produce mT {Py808A) or that produce a truncated, nonmembrane bound mT {Py138In 
have PA levels similar to that of control cells. Cells expressing the 322YF mutant of mT {which abolishes interaction of mT 
with phospholipase C y 1) show increases in both PA levels and PL-0 activity that are similar to those seen with wild-type 
mT. Expression of mutants that abolish the interaction of mT with either she or with phosphatidylinositol 3-kinase {250YS 
and 315YF, respectively) cause an increase in PL-0 activity comparable to that seen with wild-type mT. However, the PA 
content of cells expressing these mutants is not elevated. These results suggest that mT causes activation of cellular PL-
0, but this activation alone is not sufficient to cause an increase in cellular PA content. Therefore, wild-type mT must affect 
another, as yet unknown, step in PA metabolism. © 1997 Academic Press 
INTRODUCTION 
Polyomavirus is a small DNA tumor virus that causes 
multiple types of tumors when inoculated into newborn 
mice (Eckhart, 1990). The genome of polyomavirus en-
codes six proteins, three structural proteins, and three 
tumor (or T) antigens. The large T protein is localized 
mainly in the nucleus and functions in the control of viral 
transcription and replication (Eckhart, 1990). The function 
of small T, a cytosolic protein, is poorly understood. Mid-
dle T (mT), the oncogene of polyomavirus (Benjamin, 
1982; Benjamin and Vogt, 1990; Treisman et a/., 1981 ), 
plays a role in the assembly of the polyomavirus capsid 
(Garcea eta/., 1985). The mT protein also associates 
with and .activates the tyrosine kinase activity of the pro-
tooncogene product c-src (Courtneidge and Smith, 1983; 
Cartwright et a/., 1985). This primary interaction of viral 
and cellular proteins triggers a cascade of signal trans-
ducing events similar to that seen when growth factors 
are added to quiescent cells. Activation of c-src kinase 
activity causes the phosphorylation of the mT protein on 
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three tyrosine residues: Y-250, Y-315, and Y-322. The 
phosphorylation of these tyrosine residues leads to the 
binding of other signaling proteins to the mT/c-src com-
plex. Phosphotyrosine at position 250 of mT is recog-
nized by the adapter protein she (Campbell eta/., 1994; 
Dilworth eta!., 1994). Presumably, this interaction leads 
to the activation of ras seen in mT-expressing cells (Di 
Jesso et a!., 1995; Brownell et a/., 1996) as does the 
phosphotyrosine-mediated interaction between she and 
growth factor receptors (Feig, 1993; Schlessinger, 1993). 
Phosphotyrosine-315 is recognized by p85, the regulatory 
subunit of phosphatidylinositol 3-kinase (PI3-K) (Whitman 
et a/., 1985; Courtneidge and Heber, 1987; Talmage et 
a/., 1989; Auger eta/., 1992). This association leads to an 
elevation of the cellular content of phosphatidylinositol 
(3,4,5)trisphosphate in polyomavirus-transformed cells 
(Serunian eta/., 1990). Phosphotyrosine at 322 is recog-
nized by phospholipase C 'Y 1 (Su eta/., 1995) and leads 
to the activation of PL-C activity and the elevation of 
inositol (1 ,4,5)-trisphosphate (IP3) levels observed in poly-
omavirus-transformed cells (Gorga eta/., 1990; Ulug et 
a/., 1990). Protein phosphatase 2A, a serine/threonine 
phosphatase involved in signaling pathways, has also 
been found to associate with both small T and mT pro-
teins from polyomavirus (Pallas eta!., 1990; Walter eta!., 
1990). This interaction is not dependent on phosphotyro-
sine containing sequences in mT (Campbell eta!., 1996; 
Glenn and Eckhart, 1996). 
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One of the strengths of polyomavirus as a model sys-
tem for the study of oncogenic transformation is the large 
number of well-characterized mutants of mT. Some of 
the most useful mutants, with regard to signal transduc-
tion, are site-directed mutants that replace the sites of 
tyrosine phosphorylation on mT with other residues. The 
315YF mutant (originally called 1178T) replaces Y-315, 
the major site·of phosphorylation in vivo, with a phenylal-
anine. Biologically, this mutant shows a partially trans-
formed phenotype in cell culture experiments (Carmi-
chael et at., 1984) and an altered tumor profile when 
inoculated in animals (Talmage et at., 1989). Biochemi-
cally, 315YF mT has been found to activate the tyrosine 
kinase activity of c-src to the same extent as the wild 
type (Talmage et at., 1989). However, this mT fails to 
bind and activate PI3-K (Talmage et at., 1989). The 250YS 
mutant of mT replaces Y-250, a minor site of phosphoryla-
tion in vivo (Young et at., 1995), with a serine. This mutant 
is also weakly transforming of cells in culture (Dahl et 
at., 1996; C. Vasudevan and F. R. Gorga, unpublished 
results) and exhibits an altered tumor profile when inocu-
lated into animals (R. Freund, manuscript in preparation). 
Biochemically, mutants that replace Y-250 of mT with 
other residues are unable to associate with the she pro-
tein (Campbell et at., 1994; Dilworth et at., 1994; Dahl et 
at., 1996) and are presumably defective in the activation 
of res-dependent pathways. The 322YF mutant replaces 
the tyrosine at position 322 of mT with a phenylalanine; 
phosphorylation at this site allows mT to associate with 
PL-Cy1 (Su et at., 1995). Both the 322YF mutant (C. Vasu-
devan and F. R. Gorga, unpublished) and the dl1014 mu-
tant of polyomavirus (Schaffahusen et at., 1985), which 
encodes a mT protein containing a small deletion that 
includes Y-322, are fully transforming. Two nontrans-
forming polyomavirus mutants have also been used in 
the experiments reported herein. Py1387T contains a 
stop codon within the mT gene and produces a truncated 
mT antigen that lacks the carboxyl terminal 37 amino 
acids. This mutation removes the hydrophobic sequence 
that anchors mT to the plasma membrane (Carmichael et 
at., 1982). The 808A mutation of polyomavirus introduces 
changes to the splice acceptor site of the mT gene and 
fails to produce mT protein (Liang et at., 1984). Viruses 
containing either the 1378T or the 808A mutation fail to 
activate c-src kinase activity and are nontransforming. 
These mutants of mT represent tools that are extremely 
useful to "sort out" the relationship between various sig-
nal transducing pathways. 
Herein, we investigate the effect of mT expression on 
signal transduction involving the phospholipase D (PL-
D)-mediated hydrolysis of phospholipids. This signal 
transduction system is activated by many extracellular 
st!muli, including mitogens (Billah and Anthes, 1990; 
Boarder, 1994; Morris et at., 1996). The direct product of 
the hydrolysis of phospholipids by PL-D is phosphatidic 
acid (PA). Cells via a number of pathways can further 
metabolize PA. Lysophosphatidic acid (LPA) can be pro-
duced from PA by the action of phospholipase A2 (Moole-
naar, 1995). Both PA and LPA have received a great 
deal of attention, as second messengers involved in cell 
growth and differentiation. PA has been shown to stimu-
late DNA synthesis (Moolenaar et at., 1986; Fukami and 
Takenawa, 1992; Van Carven et at., 1992), cause changes 
in intracellular Ca2+ levels (Exton, 1990 and references 
therein; Moolenaar et at., 1986), and induce expression 
of the protooncogenes c-fos and c-myc (Van Carven et 
at., 1992). LPA has been shown to be at least as potent as 
PAin stimulating DNA synthesis (Fukami and Takenawa, 
1992; Van Carven, 1992). LPA also causes alterations 
in the cytoskeleton similar to those seen when peptide 
growth factors are added to cells. These alterations in-
clude rapid formation of actin stress fibers and focal 
adhesions in serum-starved Swiss 3T3 cells (Ridley and 
Hall, 1992) as well as tyrosine phosphorylation of 
p125FAK. paxillin, and gp 130 in an actin-dependent man-
ner (Seufferlein and Rozengurt, 1994). PA can also be 
converted to diacylglycerol (DAG), another important sec-
ond messenger, by a specific PA phosphatase (Exton, 
1990 and references therein). This reaction may be im-
portant in the sustained production of DAG that is ob-
served following mitogenic stimulation of some cells (Fu-
kami and Takenawa, 1989; Song et at., 1991; Wright et 
at., 1992). PL-D has been shown to be activated in a 
variety of cells by a number of different mitogens, includ-
ing platelet-derived growth factor (Plevin et at., 1991; Kiss, 
1992), epidermal growth factor (Cook and Wakelam, 
1992; Fisher et at., 1991; Fu et at., 1992; Kazskin, 1992; 
Wright et at., 1992), basic fibroblast-derived growth factor 
(Ahmed et at., 1994), serum (Kiss, 1992), bradykinin (Fu 
et at., 1992), endothelin (Kester et at., 1992), LPA (Van 
der Bend et at., 1992), and insulin (Standaert et at., 1996). 
Thus, PA (and/or LPA) are clearly involved in the mito-
genic response and may be involved in a number of 
aspects of the transformed phenotype. 
The details of the molecular events involved in the 
regulation of PL-D enzymes and the characterization of 
the enzymes themselves are the subject of much current 
research. There is evidence for multiple isoforms of PL-
D, which vary in their substrate specificity (Song et at., 
1991 ), their regulation (Song and Foster, 1993), and their 
subcellular localization (Wang et at., 1991; Siddiqi et at., 
1995 and references therein). There is also evidence for 
multiple mechanisms for the regulation of PL-D activity 
in cells. In some systems, PL-D activity is stimulated by 
the addition of phorbol esters, suggesting a role for pro-
tein kinase C in the regulation of PL-D (reviewed in Exton, 
1994). "Nonhydrolyzable" GTP analogs have been shown 
to stimulate PL-D activity in some systems (also reviewed 
in Exton, 1994). This effect is mediated in some cases 
by heterotrimeric G proteins and in others by the small 
G proteins. Both ADP ribosylation factors (ARFs) (Brown, 
1993; Cockcroft et at., 1994; Malcolm et at., 1994; Zhang 
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et a/., 1995; Bourgoin et a/., 1995} and Rho A (Bowman 
et a/., 1993; Siddiqui et a/., 1995; Ohguchi et a/., 1996} 
have been implicated in the regulation of PL-D. Proteins 
that negatively regulate PL-D have also been identified 
recently (Kim eta/., 1996; Geny eta/., 1995}, although the 
significance of such regulation is not clear. Gelsolin, a 
protein that interacts with the cytoskeletal protein actin 
and with phosphatidylinositol (4,5}bis-phosphate have 
been recently shown to mediate the regulation of phos-
phoinositide stimulation of PL-D (Steed eta/., 1996}. 
The relationship between oncogenic transformation 
and PL-D activity has not been well characterized. Fibro-
blasts transformed with either v-src (Song and Foster, 
1993} or v-fps (Jiang eta/., 1994} have been shown to 
possess increased PL-D activity compared to their non-
transformed counterparts. The activation of PL-D by v-
src is associated with increased cellular levels of PA and 
DAG (Song et a/., 1991} and is dependent on the ras/ 
ral pathway (Jiang eta/., 1995, 1996}. In this report, we 
investigate the cellular levels of PA, DAG, and PL-D activ-
ity in various cell lines expressing wild-type or mutant 
mT genes. 
MATERIALS AND METHODS 
Materials 
Dulbecco's modified Eagle's medium (DMEM}, penicil-
lin/streptomycin, mycostatin, dexamethasone, and calf 
serum were from Sigma. [32P]inorganic phosphate 
([32P]P;}, carrier-free, and b'-32P]ATP (3000 Ci/mmol} were 
purchased from DuPont New England Nuclear. Silica thin 
layer chromatography (TLC} plates were from J. T. Baker. 
These plates were pretreated by soaking in 0.1 M dipo-
tassium ethylenediamine tetra acetate in 50% ethanol and 
dried in an oven at 100° for 2 hr before use. Phospholipid 
standards were purchased from Sigma, except for DAG 
and phosphatidylpropanol (PPr}, which was from Avanti 
Polar Lipids. Cardiolipin and DAG kinase for the determi-
nation of DAG were purchased from Avanti and Calbio-
chem, respectively. 
Cells and cell culture 
All of the cells used in these experiments were derived 
from the F111 rat fibroblast line (Freeman et a/., 1973; 
Schlegel and Benjamin, 1978}. PyF cells, described pre-
viously (Feunteun et a/., 1976}, are derived from foci of 
transformed cells resulting from the infection of F111 
cells with wild-type polyomavirus (series I in Table 1}. 
The mt-1 cell line, which expresses the mT eDNA under 
control of the dexamethasone inducible MMTV-LTR pro-
moter (Raptis eta/., 1985}, was also used in some experi-
ments (series II, Table 1}. 
In order to study the effect of nontransforming and 
weakly transforming mT genes, cell lines (series 111-V, 
Table 1} that stably express these genes were con-
structed using the BamHI to EcoRI fragment of wild type 
and several mutant polyoma genomes that were pre-
viously subcloned into pUC18. This DNA fragment in-
cludes the regulatory sequences necessary for transcrip-
tion, and the sequences encoding intact small T and 
middle T proteins, as well as an amino-terminal fragment 
of large T antigen (residues 1 to 334}. The Fneo• Fneo 1178T, 
FneoNG59, and Fnaowt set of cells (series Ill} have been 
described previously (Gorga eta/., 1990}. In order to study 
the effects of other mutant mT proteins, series IV and V 
(Table 1} of cells were constructed using the BamHI to 
EcoRI of wild-type (PTA} or mutant (Py250YS, Py315YF, 
Py322YF, Py808A, and Py1387T} polyomavirus genomes 
subcloned into pUC18. These plasmid DNAs were co-
transfected with pSV2neo (a plasmid that encodes the 
G418 resistance gene} into F111 cells using the calcium-
phosphate method. G418-resistant colonies were iso-
lated and screened for expression of middle T antigen 
by Western blot analysis. Several independent clones 
expressing the various wild-type or mutant middle T anti-
gens were expanded and used for subsequent studies. 
Control cell lines (M(6} and Neo} were selected by G418 
resistance after transfecting F111 cells with only the 
pSV2neo plasmid. 
The growth of these new cell lines (series IV and V} 
in soft agar (1 0% serum} was examined using standard 
methods (data not shown}. As expected cells expressing 
wild-type mT (PTA (1'} and (2}} grew as large colonies 
similar to those seen with both PyF and Fneowt cells. 
Control cells (M(6} and Neo} as well as cells expressing 
nontransforming mutants (Py808A and PY1387T} did not 
grow under these conditions. Cells expressing the 315YF 
mutation of mT (Py315YF} have properties similar to the 
older cell line (Py1178TF} expressing the same mutation. 
These cells, along with the Py250YS cell line, grew as 
colonies that were clearly smaller than those produced 
by cells expressing wild-type mT. Last, cells expressing 
the 322YF mutant of mT grew as large colonies, similar 
to those seen with cells expressing wild-type mT. 
Cells were routinely grown in DMEM supplemented 
with 10% calf serum, penicillin/streptomycin, and myco-
statin in a 5% C02 atmosphere at 37°. In all experiments, 
cells were subconfluent when lipids were extracted. 
Labeling of cells with [32P]P; 
Cells were passed at a density of 1 to 2 X 105 cells 
per 60-mm plate and cultured overnight. The medium 
was then replaced with phosphate-free DMEM supple-
mented with 2% calf serum, penicillin/streptomycin, and 
containing 15-25 J.LCilml of [32 ~]P;. Preliminary experi-
ments showed that steady state labeling of phospholip-
ids was achieved by 24 hr after the radiolabel was added 
and that the specific activity of the phospholipids in the 
various cell lines was· similar (results not shown}. 
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Induction of mT expression in mt-1 cells 
For experiments involving the mt-1 cell line, cells were 
passed and radiolabeled as described above, except that 
calf serum, treated with activated charcoal to reduce en-
dogenous sterols, was used. Dexamethasone (1 JLMfinal. 
concentration) was added to the radiolabeling media 
where appropriate. Thus, cells were exposed to dexa-
methasone for 28 to 30 hr before lipids were extracted. 
Mt-1 cells maximally express the mT gene product in 8 
hr after induction and acquire a transformed morphology 
at this concentration of dexamethasone (Raptis et a/., 
1985). There was no effect of dexamethasone on the 
morphology of F111 cells. 
Determination of cellular PA levels 
Between 24 and 30 hr after labeling, media was re-
moved from the plates, the monolayers were washed 
with 5 ml of ice-cold phosphate-buffered saline con-
taining 1 mM CaCI2 and 1 mM MgCI2 , and lipids were 
extracted with 600 JLI ice-cold CHCI3 :CH30H:concen-
trated HCI (2:1 :0.01, by volume). After transfer of the lipid 
extract to a 1.5-ml microcentrifuge tube, 300 JLI each of 
CHCI3 and 2M NaCI were added to cause phase separa-
tion. The mixture was then vortexed and spun in a micro-
centrifuge at 4°. The lower phase was removed and dried 
under a stream of nitrogen. The dried lipids were immedi-
ately dissolved in 25 JLI of CHCI3 :CH30H (1 :2, by volume) 
and spotted on pretreated silica TLC plates. Lipids were 
separated using ethyl acetate:2,2,4-trimethylpentane:gla-
cial acetic acid (9:5:2, by volume). After drying, the TLC 
plates were exposed to X-ray film in the presence of 
an intensifying screen at -70°. Radiolabeled lipids were 
identified by comparison with unlabeled standards (lo-
cated by staining with iodine). Lipids were scraped from 
the TLC plates and the associated radioactivity was 
quantitated by liquid scintillation counting. 
Determination of cellular DAG levels 
Cells were passed at a density of 4 to 6 x 1 05 cells 
per 1 00-mm plate and cultured for 96 hr. Media was 
removed from the plates and the monolayers were 
washed three times with 10 ml of phosphate-buffered 
saline. Seven milliliters of phosphate-buffered saline was 
added to each plate and the cells were removed by 
scraping with a rubber policeman. Cells were pelleted 
by centrifugation at 4° and resuspended in 400 JLI of 
phosphate-buffered saline. A 40-JLI portion of this cell 
suspension was reserved for protein determination and 
400 JLI of CHCI3 :CH30H (2:1) added to the remainder. 
CHCI3 (350 JLI} and 250 JLI of 1 M NaCI were added to 
the sample in order to obtain a two phase system. The 
phases were separated by centrifugation and 400 JLI of 
the lower phase was transferred to a new tube. After 
evaporation of the solvent using a N2 stream, the amount 
of DAG in these samples was determined by conversion 
of the DAG to [32P]PA using [y-32P]ATP and bacterial DAG 
kinase following the method of Preiss et at. (1986). A 
minimum of four known amounts of DAG were run along 
with each batch of cell extracts in order to construct a 
standard curve. Total cellular protein in each sample was 
determined using the assay described by Bradford (1976) 
with reagent obtained from Bio-Rad. 
Determination of PL-D activity in cells 
PL-D carries out a unique transphosphatidylation reac-
tion in the presence of alcohols such as ethanol or n-
propanol (Billah and Anthes, 1990 and references 
therein). Thus, the activity of PL-D in cells can be indi-
rectly assayed by measuring the amount of the phospha-
tidylalcohol produced by the cells in the presence of a 
simple alcohol. Cells labeled with [32P]P; for 24-30 hr 
were incubated with n-propanol (1% by volume) for 10 
min. Lipids from the cells exposed to n-propanol were 
extracted and separated as described above. PPr was 
identified by its comigration with a standard and quanti-
tated as described above. Preliminary experiments 
showed that phosphatidylpropanol accumulation was lin-
ear for at least 60 min and that 1% n-propanol did not 
affect cell viability (as assessed by trypan blue exclusion) 
over this interval (data not shown). 
Data analysis 
Determinations of PA and PPr were normalized for 
plate-to-plate variations by reporting the PA and PPr as 
a percentage of the total counts recovered from each 
lane of the TLC plate. The total radioactivity recovered 
from a single lane was usually in the range of 0.5 million 
to 1.5 million cpm. Since the specific activity of the [32P]-
phospholipids in all three cell lines is constant, this is 
essentially the same as normalizing to cell mass. Deter-
minations of DAG were normalized to the total cellular 
protein in each sample. Generally, data from a number 
of separate experiments were pooled for analysis. Statis-
tical outliers, as determined by the Q test (Dean and 
Dixon, 1951) were omitted. Data is reported as mean ± 
standard error of mean (SEM) for multiple determina-
tions. Statistical significance was determined using Stu-
dent's t test. A P value less than 0.05 was taken to indi-
cate a statistically significant difference. 
RESULTS 
Transformation of fibroblasts by mT is associated 
with elevation of cellular PA levels 
Transformation of F111 rat fibroblasts by polyomavirus 
mT causes an approximately 50% elevation of cellular 
PA levels compared to the control cell lines. This effect 
was observed in a number of independently derived cell 
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TABLE 1 
Cellular PA Levels in Various Cells 
Cellular PA level 
Percentage of Percentage of 
Series• Cell line total cpmb control cells 
F111 0.257 ::!: 0.022 (8) 
PyF 0.386 ::!: 0.021 (1 0} 0 150 
II F111 0.360::!: 0.020 (10) 
F111 + Dex. 0.380 ::!: 0.098 (9) 95 
mt-1 0.326 ::!: 0.021 (13) 
mt-1 + Dex. 0.562 ::!: 0.072 (12}0 172 
Ill Fneo 0.387 ::!: 0.056 (33) 
Fneowt 0.519 ::!: 0.098 (31} 0 134 
Fneo 1178T 0.363 ::!: 0.043 (34) 94 
FneoNG59 0.343 ::!: 0.064 (9) 89 
IV M (6) 0.331 ::!: 0.013 (71) 
PTA (1') 0.383 ::!: 0.016 (19}0 116 
(2) 0.473 ::!: 0.016 (27}0 143 
Py250YS (1') 0.190::!: 0.012 (15)" 57 
(2) 0.273::!: 0.015 (10}0 83 
(4) 0.366::!: 0.010 (10)0 110 
Py315YF (2) 0.270 ::!: 0.019 (18) 82 
(3) 0.331 ::!: 0.025 (10) 100 
Py808A 0.305 ::!: 0.022 (8) 92 
Py1387T 0.280::!: 0.016 (8) 85 
v Neo 0.497 ::!: 0.023 ( 11} 
Py322YF (4) 1.549 ::!: 0.049 ( 11}0 312 
• Five different series of cell lines were used (see Materials and 
Methods for details). Series I consists of F111 and its polyomavirus-
transformed counterpart, PyF. Series II consists of mt-1 cells in which 
the expression of the mT eDNA is inducible by dexamethasone. Series 
111-V consists of cell lines derived (at different times) from F111 by 
transfection of plasmids containing a fragment of the early region of 
polyomavirus. Since the various series were independently derived 
over a period of years, and since the control cell lines (F111, Fneo, 
M(6) and Neo) show small variations in their PA content, we have 
chosen to treat the data collected with each series independently. 
b Mean ::t SEM (n}, where n is the sample number. 
c These values were significantly different from PA levels in the ap-
propriate controls (P < 0.05). 
lines (Table 1 ). PyF cells, transformed by infection of F111 
cells with polyomavirus and selected on the basis of their 
transformed phenotype show a 50% increase in PA level 
compared to F111 cells (series I, Table 1). The mt-1 cell 
line, which contains the mT eDNA under the control ofthe 
dexamethasone-inducible mouse mammary tumor virus 
promoter, exhibits a 70% increase in cellular PA upon 
the addition of dexamethasone (series II, Table 1). This 
effect of dexamethasone is specific to the mt-1 cell line 
since the cellular level of PAin F111 cells is not affected 
significantly by the addition of dexamethasone. FneoWt 
(series Ill). PTA (1 '),and PTA (2) (series IV), which consti-
tutively express mT, small T, and a fragment of large T, 
shows on an average a 32% increase in cellular PA levels 
compared to appropriate control cell lines (Table 1 ). 
We have also determined the effect of expression of 
various mT mutants on cellular PA levels (series Ill, IV, 
and V, Table 1). Mutations that abolish the transforming 
ability of polyomavirus (FneoNG 59 (series Ill) and Py808A 
and Py1387T (series IV)) fail to cause the increase in PA 
levels seen with wild-type mT expressing cells. Similarly, 
the mutants of mT (Fneo 1178T (series Ill) and Py250YS 
and Py315YF (series IV)), which abolish the binding of 
either she or PI-(3)K to mT/c-src complex, also fail to 
cause elevation of cellular PA levels. In fact, two clones 
(of the three tested) expressing Py250YS mT show PA 
levels that are significantly lower than the control cell 
line, M(6) (Table 1 ). Cells expressing the 322YF mutant 
of mT (Py322YF, series V) also have significantly higher 
(a 200% increase) levels of PA as compared to its control, 
Neo (Table 1 ). Thus, cells expressing fully transforming 
mT proteins show an increase in cellular PA content 
compared to untransformed cells. Cells expressing either 
nontransforming or weakly transforming mutants of mT 
show no changes in cellular PA level. 
Elevation of cellular PL-0 activity by expression of mT 
The PL-0-mediated hydrolysis of phospholipids that 
results in the formation of PA has been recently recog-
nized as an important event in cellular signaling. We have 
measured the level of PL-0 activity in cells using the 
transphosphatidylation activity associated with this en-
zyme. These data clearly show that PyF cells exhibit 
about 42% increase in PL-0 activity compared to F111 
cells (Fig. 1 ). Similarly, the addition of dexamethasone to 
mt-1 cells (to induce expression of mT protein) causes 
a 94% increase in PL-0 activity compared to cells which 
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FIG. 1. PL-D activity in normal (F111) and polyomavirus-transformed 
(PyF) cells. In vivo enzymatic activity was measured by the formation 
of [32P]phosphatidylpropanol (PPr) in [32P]P, labeled cells (see Materials 
and Methods for details). The values shbwn are mean ::!: SEM. Data 
was pooled from multiple experiments and sample number (n) was 26 
(F111) and 14 (PyF) for the 2 cell lines. The increase in PPr accumulation 
seen in the PyF cells compared to F111 cells is statistically significant 
(P < 0.003). 
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FIG. 2. PL-D activity in mt-1 cells expressing the mT eDNA and in 
F111 cells in the presence (shaded bars) and absence (open bars) of 
dexamethasone (DEX). Cells were exposed to dexamethasone for 28 
hr during (32P]P; labeling (see Materials and Methods for details). Only 
the mt-1 cells acquire a transformed phenotype under these conditions. 
Values shown are mean ± SEM for 8 to 10 determinations pooled from 
several experiments. PL-D activity in mt-1 cells exposed to dexametha-
sone is significantly higher than that seen in mt-1 cells that were not 
exposed to dexamethasone (P < 0.005). There was no difference in 
PL-D activity in F111 cells with or without dexamethasone. 
were· uninduced (Fig. 2). This effect is specific for the 
expression of mT in mt-1 cells, as dexamethasone has 
no effect on PPr accumulation in F111 cells. 
Two cell lines, Py322YF(4) and (5), which express the 
322YF mutant of mT, also shows a significantly higher 
level of PL-D activity (mean increase of 77%) compared 
to the control cell line, Neo (Table 2). The cellular PA 
content of Py322YF(4) cells is elevated to levels similar 
to that seen in cells expressing wild-type mT (Table 1 ). 
Cell lines expressing the 250YS or 315YF mT mutants 
also show significant increases in PL-D activity com-
pared to control cells (Table 2), even though these cell 
TABLE 2 
PL-D Activity in Series IV and V Cells 
PL-D Activity 
Parentage of Percentage of 
Series• Cell line total cpmb control cells 
IV M (6) 0.129 ± 0.013 (14) 
Py250YS {4) 0.181 ± 0.008 (8)0 140 
Py315YF (2) 0.201 ± 0.021 (9)0 156 
PTA(2) 0.243 ± 0.019 (17)0 188 
v Neo 0.111 ± 0.009 {18)0 
Py322YF (4) 0.230 ± 0.021 (12)0 207 
(5) 0.167 ± O.Q18 {6)0 151 
.!'See footnote a in Table 1. 
b Mean ± SEM of n determinations. 
c Values are significantly different {P < 0.05) from appropriate control 
cell line. 
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FIG. 3. Cellular DAG levels in F111, Py1178TF, and PyF cells as 
measured by the method of Preiss et a/. (1986). See Materials and 
Methods for experimental details. The values shown are mean ± SEM 
for either 21 (F111) or 24 (Py1178TF and PyF) determinations. Data 
was pooled from multiple experiments. The difference in DAG content 
between F111 and PyF cells is statistically significant (P < 0.04). 
lines had only control cell-like cellular PA levels (Table 
1 ). Thus, although an increase in PL-D activity is associ-
ated with increases in cellular PA levels induced by mT, 
the increase in PL-D activity is not sufficient to cause a 
corresponding increase in cellular PA levels in all the 
cell lines. 
Cellular DAG levels are unaffected by polyomavirus 
transformation 
One possible metabolic role for the PA produced via 
the action of PL-D is to serve as a precursor for the 
second messenger, DAG (Boarder, 1994; Exton, 1994). 
Therefore, we determined the DAG levels in normal and 
polyomavirus-transformed cells using the method of Pre-
iss eta/. (1986). The normal F111 cell line and the partially 
transformed Py1178TF cell line have similar levels of 
DAG, while the completely transformed PyF cells had 
significantly less (about 40% lower) DAG compared to 
the F111 cells (Fig. 3). It is interesting to note that only 
the fully transformed PyF cells had significantly elevated 
PA levels compared to the normal cells (Table 1 ). 
DISCUSSION 
Transformation of rat fibroblasts by polyomavirus 
causes an approximately 50% increase in their PA con-
tent. This increase in cellular PA is due solely to the 
expression of mT, since this effect is seen in cells which 
express a mT eDNA (mt-1, see Table 1 ). Since the same 
result is obtained using a number of independently de-
rived cell lines, the increase in cellular PA levels we 
observe is neither due to a random clonal variation nor 
is it affected by the method used to introduce the mT 
gene into the fibroblasts. 
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Further evidence supporting the role of mT in the ele-
vation of cellular PA levels comes from cell lines that 
contain mutant polyomavirus genome fragments. Cells 
that express only a sT (but no mT, series IV, Py808A) or 
small T and a truncated mT gene (series IV, Py1387T) 
have PA levels similar to control cells, M(6). Thus small 
T alone is not sufficient to cause elevation of cellular PA 
levels. 
In order to investigate the enzymatic basis for the mT-
induced elevation of cellular PA content we examined 
the activity of PL-0 in cells expressing either wild-type 
or mutant mT. PyF cells (Fig. 1) and mt-1 cells induced 
to express mT (Fig. 2) show about a 43 and a 94% in-
crease in PL-0 activity, respectively, as measured by PPr 
accumulation. Likewise, the PTA (2), Py322YF (4), and 
Py322YF (5) cell lines show significant increases in PL-
0 activity compared to their control cell lines (Table 2). 
Thus, the increase in cellular PA observed in cells ex-
pressing wild-type mT is due, at least in part, to an in-
crease in PL-0 activity. 
Activation of PL-0 in cells transformed by wild-type 
polyomavirus causes an elevation of cellular PA level 
without altering cellular DAG content (Fig. 3). This result 
suggests that PA is not significantly converted to DAG 
in these cells or that the subsequent metabolism of DAG 
is rapid (relative to the rate at which it is produced). This 
observation is unexpected in light of previous results, 
demonstrating that mT causes elevation of cellular inosi-
tol phosphate levels (Gorga et at., 1990; Ullug et at., 1990), 
since DAG is also produced via action of phospholipase 
C. This apparent discrepancy may be due to a rapid 
metabolism of DAG or to the fact that the phosphatidyl-
inositol(4,5)bisphosphate content of F111 cells is rela-
tively small compared to their DAG content. 
The elevation of cellular PA levels caused by mT re-
quires the activation of c-src kinase activity and the tyro-
sine phosphorylation of mT. Expression of the 1387T or 
the NG59 mutants of mT, both of which fail to activate 
the kinase activity of c-src (Carmichael eta/., 1982; Bolen 
et at., 1984, respectively), also fail to increase cellular 
levels of PA. Expression of mT proteins containing either 
the 315YF mutation or the 250YS mutation, but not the 
322YF mutant, also fail to increase cellular PA levels. 
Thus, the elevation of cellular PA levels caused by mT 
is dependent on the phosphorylation of tyrosine residues 
that are known to be involved in the interaction of mT 
with other signal transducing proteins. 
The elevation in PA level (Table 1) and the activation 
of PL-0 (Table 2), seen in the Py322YF cell line suggests 
that the phosphorylation of tyrosine residue 322 and 
events occurring downstream to it (association of PL-
C'Y1 with mT (Su et at., 1995) and increased IP3 produc-
tion (Gorga et at., 1990)) are not involved in the regulation 
of either of these processes. Phosphorylation of mT at 
Y315 causes the association of p85, the regulatory sub-
unit of PI3-K with mT (Talmage et at., 1989). Phosphoryl a-
tion of mT at Y-250 causes the association of she with 
mT (Campbell et at., 1994; Dilworth et at., 1994). Since 
the increase in cellular PA levels by mT are abolished 
by the mutation of either Y-250 orY-315, we can conclude 
that the association of both p85 and she to mT/c-src are 
necessary for elevating PA level. Since the she protein, 
via grb2, activates sos, a ras-specific guanine nucleotide 
releasing factor (Feig, 1993; Schlessinger, 1993), our re-
sults with the 250YS mutant suggest a requirement for 
ras in the elevation of PA levels. 
Interestingly, neither the 250YS nor the 315YF muta-
tions of mT affect the activation of PL-0 caused by mT. 
This result suggests that the activation of PL-0 alone is 
not sufficient to increase cellular PA content and that at 
least one other step in PA metabolism is affected by mT. 
The identity of this "second step" is, at present, unknown. 
However, the small decrease in DAG content seen upon 
polyomavirus transfection suggests two possibilities for 
this "second step." Inhibition of cellular PA phosphatase 
activity would be expected to increase cellular PA levels 
independently of changes in PL-0 activity and might (de-
pending on the relative rates of DAG production and 
utilization) cause a decrease in cellular DAG level. Alter-
nately, mT could act, with the same result, by stimulating 
DAG kinase (DGK). Stimulation of DGK would cause the 
production of PA independently of PL-0 and again, might 
cause a decrease in cellular DAG content. Obviously, 
further work will be necessary to fully understand the 
effect of mT on cellular PA metabolism. Whatever the 
nature of this "second step" is, its regulation by mT, is 
clearly dependent on the phosphorylation of tyrosines 
250 and 315 of mT and presumably events "downstream" 
of this phosphorylation. 
The increase in PL-0 activity caused by mT is clearly 
not dependent on any of the signal transducing pathways 
"downstream" from the tyrosine phosphorylation of mT. 
The molecular events linking mT to PL-0 are not known. 
One possible link is the activation of c-src kinase activity, 
per se. One report (Lin et at., 1994) showing that PL-0 
activity is found in anti-phosphotyrosine immunoprecipi-
tates is, at least, consistent with this idea. Another possi-
ble link between mT and PL-0 is the serine/threonine-
specific protein phosphatase 2A (PP2A). PP2A associ-
ates with both mT and sT of polyomavirus (Pallas et at., 
1990). Recently it had been proposed that the formation 
of the mT/c-src complex itself depends upon the binding 
of PP2A to mT (Campbell et at., 1996; Glenn et at., 1996). 
The binding of PP2A to mT seems to require the amino 
terminus of mT (residues 1-25) and also the region of 
mT comprising residues 105-111 (Campbell et at., 1996; 
Glenn et at., 1996). It is likely that site-directed mutations 
in the C-terminal region of mT •. such as 250YS, 315YF, 
or 322YF, would not interfere with the binding of PP2A 
to mT. Thus proteins containing these mutations, all of 
which activate PL-0, should bind PP2A. Another possibil-
ity for the molecular nnk between mT and PL-0 is the 
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proline-rich region of mT near residue 340. This proline-
rich region may represent a motif by which mT can inter-
act with an unknown protein containing an SH3 domain. 
The dl1015 mutant of polyomavirus, which encodes a 
small deletion in this region, is weakly transforming (Ma-
gunsson and Berg, 1979) even though it associates with 
both c-src and PI 3-kinase (Uiug eta/., 1990; Ling eta/., 
1992). 
It is interesting to contrast our results with those of 
Foster and coworkers, who have investigated PA metab-
olism in v-src-transformed cells. Transformation of cells 
with the v-src oncogene causes activation of PL-D activity 
and increased cellular PA levels (Jiang eta/., 1994; Song 
eta/., 1991). These events are also associated with an· 
increase in cellular DAG levels (Song eta/., 1991 ). Experi-
ments involving the expression of dominant negative mu-
tants of both ras and raf-1 demonstrate that the activation 
of PL-D by v-src is dependent on ras but not raf-1, a 
serine/threonine protein kinase activated by ras (Jiang et 
a/., 1995). It is interesting to note that v-src transformed 
cells expressing the dominant negative mutants of ras 
(Jiang eta/., 1995) and thus a normal level of cellular PA 
show a partially transformed phenotype, similar to that 
seen with cells expressing the 250YS or 315YF mutants 
of mT. 
We have shown that expression of polyomavirus mT 
causes an increase in both cellular PA content and in 
PL-D activity. However, results with two mutants of mT 
show that the increase in PL-D activity is not sufficient 
for the elevation of cellular PA levels. Thus, mT must 
affect a second enzyme involved in cellular PA metabo-
lism. We suggest that this second enzyme is PA phos-
phatase. Clearly more experiments are needed to sup-
port this hypothesis and to determine the molecular 
mechanism(s) by which mT affects both PL-D and PA 
metabolism, in general. 
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